Maryland’s Opioid Restitution Fund

Advisory Council Membership | Public Reports | Settlement Overview | Use of ORF Funds

Maryland’s Opioid Restitution Fund (ORF) was established in 2019 to receive all monies awarded to the State of Maryland through prescription opioid-related legal action. In 2022, Maryland established the ORF Advisory Council to provide recommendations regarding the use of those funds.

Resources

• State-Subdivision Agreement (January 2022 – Janssen)
• State-Subdivision Agreement (April 2023 – Teva, Allergan, & Walmart)
• Janssen Settlement – Exhibit E (allowable uses)
• Statutory Mandate (updated in 2024 with Senate Bill 751)
• 2023 ORF Advisory Council Funding Recommendations
• 2024 ORF Advisory Council Funding Recommendations
• 2024 Public Reporting Recommendations for Opioid Restitution Fund Expenditures

Prescription Opioid Settlement Information

As of the 2024 fiscal year (July 1, 2023 – June 30, 2024), Maryland has received distributions through seven prescription opioid-related legal settlements. Visit the Settlement Overview page for more information.

Opioid Restitution Fund Advisory Council Meetings

Next ORF Advisory Council Regular Meeting: TBD.

For questions regarding the ORF Advisory Council, email StopOverdose@maryland.gov.

Past Meetings

Special Session: Mallinckrodt Committee Meeting
Friday, November 22, 2024 (9:00–10:00 am)

Regular Meeting – Monday, October 21, 2024 (virtual)
Time: 3:00–4:00 p.m.
Agenda | Meeting Recording | Meeting Minutes

Previous Meetings Archive: Visit StopOverdose.maryland.gov/orf-past-meetings to view meeting minutes and recordings from past ORF Advisory Council meetings.

Stay in Contact!

To receive notifications regarding Maryland’s overdose crisis response efforts, please complete the following form to be added to our mailing list.

Mailing List Sign-Up Form